CN111700886A - Compound allicin soft capsule and preparation and packaging method thereof - Google Patents

Compound allicin soft capsule and preparation and packaging method thereof Download PDF

Info

Publication number
CN111700886A
CN111700886A CN202010328287.6A CN202010328287A CN111700886A CN 111700886 A CN111700886 A CN 111700886A CN 202010328287 A CN202010328287 A CN 202010328287A CN 111700886 A CN111700886 A CN 111700886A
Authority
CN
China
Prior art keywords
capsule
allicin
soft
solution
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010328287.6A
Other languages
Chinese (zh)
Inventor
肖军宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Hongkang Pharmaceutical Technology Co ltd
Original Assignee
Guangzhou Hongkang Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Hongkang Pharmaceutical Technology Co ltd filed Critical Guangzhou Hongkang Pharmaceutical Technology Co ltd
Priority to CN202010328287.6A priority Critical patent/CN111700886A/en
Publication of CN111700886A publication Critical patent/CN111700886A/en
Priority to PCT/CN2020/135064 priority patent/WO2021212865A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a compound allicin soft capsule and a preparation and packaging method thereof, wherein the compound allicin soft capsule comprises capsule contents and capsule skin, and the capsule contents comprise the following components in percentage by mass: allicin: 1% -65% and houttuynin: 1-55 percent, and the capsule skin comprises the following components in percentage by mass: sizing and excipient: 10% -20%, plasticizer: 1-10%, additive: 1-10% and water: 50% -80%, the beneficial effect of the invention is: the allicin and the houttuynine sodium bisulfite are mixed fully to prepare the broad spectrum antibiotic medicine with definite curative effect, long-term taking and no toxic side effect, and the medicine has clear components and definite action mechanism, and avoids the defects of complex traditional Chinese medicine components and unknown pharmacological action mechanism, and the defects of great toxic and side effect of chemical medicine and long-term taking.

Description

Compound allicin soft capsule and preparation and packaging method thereof
Technical Field
The invention relates to the technical field of clinical application, in particular to a compound allicin soft capsule and a preparation and packaging method thereof.
Background
With the aging development of population and the abuse of antibiotics, common clinical double infection and double infection are increasing day by day, common antibiotics such as penicillin antibiotics and cephalosporin antibiotics are artificially synthesized modified compounds and have the defects of strong drug resistance and large toxic and side effects, most common clinical chronic diseases are old patients, most of the patients have multi-organ diseases with liver and kidney insufficiency, the toxic and side effects are increased when various drugs such as antibiotics and lipid-lowering drugs are used together, and the prognosis is poor, so that a broad-spectrum antibacterial drug which has definite curative effect, can be taken for a long time and has no toxic and side effects needs to be researched.
Disclosure of Invention
The invention aims to provide a compound allicin soft capsule and a preparation and packaging method thereof, which aim to solve the problems in the background technology.
In order to realize the purpose, the invention provides the following technical scheme that the compound allicin soft capsule consists of capsule contents and a capsule skin, wherein the capsule contents comprise the following components in percentage by mass: allicin: 1% -65% and houttuynin: 1% -55%, wherein the capsule shell comprises the following components in percentage by mass: sizing and excipient: 10% -20%, plasticizer: 1-10%, additive: 1-10% and water: 50 to 80 percent.
Preferably, the allicin has the chemical formula C6H10S3And the garlicin is obtained by purifying natural plant garlic or artificially synthesizing.
Preferably, the houttuynine sodium bisulfite has chemical formula C12H22O2The houttuynin is obtained by purifying or artificially synthesizing natural plant houttuynia cordata.
Preferably, the sizing excipient is gelatin.
Preferably, the plasticizer is sorbitol or glycerol.
Preferably, the additive is a fragrance, a preservative or an opacifier.
A preparation and packaging method of a compound allicin soft capsule comprises the following steps:
s1, preparing a solution I: weighing allicin according to the formula proportion, adding into partial water, heating and stirring until the allicin is completely dissolved;
s2, preparing a solution II: weighing houttuynin according to the formula proportion, adding part of water, mixing uniformly, and stirring to dissolve completely;
s3, mixing and stirring: adding a certain amount of the first solution into a certain amount of the second solution according to the formula proportion, and stirring until the first solution is completely dissolved to obtain a mixed solution;
s4, preparing a capsule shell glue solution: weighing gelatin, plasticizer, additive and water according to a formula ratio, firstly putting the gelatin into the water, soaking to swell the gelatin, adding the plasticizer and the additive after the gelatin is dissolved, and then mixing and stirring uniformly to obtain capsule shell glue solution;
s5, preparing a capsule shell: uniformly coating the capsule shell glue solution obtained in the step (4) on the surface of a flat plate, and then heating at the temperature of about 90 ℃ to evaporate the water on the surface of the capsule shell glue solution to obtain a soft capsule with certain toughness;
s6, pressing soft capsules: putting the soft capsule obtained in the step 5 on an automatic rotary capsule pricking machine, adding the mixed solution obtained in the step 3, and pressing into soft capsules;
s7, packaging and warehousing: and (4) drying the soft capsules obtained in the step (6), inspecting the soft capsules, sterilizing at 55 ℃ after the soft capsules are qualified, then externally packaging the soft capsules, and warehousing and storing the soft capsules.
Compared with the prior art, the invention has the beneficial effects that:
the allicin and the houttuynine sodium bisulfite are mixed fully to prepare the broad spectrum antibiotic medicine with definite curative effect, long-term taking and no toxic side effect, and the medicine has clear components and definite action mechanism, and avoids the defects of complex traditional Chinese medicine components and unknown pharmacological action mechanism, and the defects of great toxic and side effect of chemical medicine and long-term taking.
Detailed Description
The invention provides a technical scheme that: a compound allicin soft capsule consists of capsule contents and a capsule skin, wherein the capsule contents comprise the following components in percentage by mass: allicin: 1% -65% and houttuynin: 1% -55%, wherein the capsule shell comprises the following components in percentage by mass: sizing and excipient: 10% -20%, plasticizer: 1-10%, additive: 1-10% and water: 50 to 80 percent.
Wherein the chemical formula of the allicin is C6H10S3And the garlicin is obtained by purifying natural plant garlic or artificially synthesizing.
Wherein the houttuynin has a chemical formula of C12H22O2The houttuynin is obtained by purifying or artificially synthesizing natural plant houttuynia cordata.
Wherein the sizing excipient is gelatin.
Wherein the plasticizer is sorbitol or glycerol.
Wherein the additive is a perfume, a preservative or an opacifier.
A preparation and packaging method of a compound allicin soft capsule comprises the following steps:
s1, preparing a solution I: weighing allicin according to the formula proportion, adding into partial water, heating and stirring until the allicin is completely dissolved;
s2, preparing a solution II: weighing houttuynin according to the formula proportion, adding part of water, mixing uniformly, and stirring to dissolve completely;
s3, mixing and stirring: adding a certain amount of the first solution into a certain amount of the second solution according to the formula proportion, and stirring until the first solution is completely dissolved to obtain a mixed solution;
s4, preparing a capsule shell glue solution: weighing gelatin, plasticizer, additive and water according to a formula ratio, firstly putting the gelatin into the water, soaking to swell the gelatin, adding the plasticizer and the additive after the gelatin is dissolved, and then mixing and stirring uniformly to obtain capsule shell glue solution;
s5, preparing a capsule shell: uniformly coating the capsule shell glue solution obtained in the step (4) on the surface of a flat plate, and then heating at the temperature of about 90 ℃ to evaporate the water on the surface of the capsule shell glue solution to obtain a soft capsule with certain toughness;
s6, pressing soft capsules: putting the soft capsule obtained in the step 5 on an automatic rotary capsule pricking machine, adding the mixed solution obtained in the step 3, and pressing into soft capsules;
s7, packaging and warehousing: and (4) drying the soft capsules obtained in the step (6), inspecting the soft capsules, sterilizing at 55 ℃ after the soft capsules are qualified, then externally packaging the soft capsules, and warehousing and storing the soft capsules.
The embodiment 1 discloses a compound allicin soft capsule, which consists of capsule contents and a capsule skin, wherein the capsule contents comprise the following components in percentage by mass: allicin: 60% and houttuynin: 40 percent, and the capsule skin comprises the following components in percentage by mass: gelatin: 15%, plasticizer: 5% of additive: 5% and water: 75 percent.
Figure RE-GDA0002633843180000041
A preparation and packaging method of a compound allicin soft capsule comprises the following steps:
s1, preparing a solution I: weighing allicin according to the formula proportion, adding into partial water, heating and stirring until the allicin is completely dissolved;
s2, preparing a solution II: weighing houttuynin according to the formula proportion, adding part of water, mixing uniformly, and stirring to dissolve completely;
s3, mixing and stirring: adding a certain amount of the first solution into a certain amount of the second solution according to the formula proportion, and stirring until the first solution is completely dissolved to obtain a mixed solution;
s4, preparing a capsule shell glue solution: weighing gelatin, plasticizer, additive and water according to a formula ratio, firstly putting the gelatin into the water, soaking to swell the gelatin, adding the plasticizer and the additive after the gelatin is dissolved, and then mixing and stirring uniformly to obtain capsule shell glue solution;
s5, preparing a capsule shell: uniformly coating the capsule shell glue solution obtained in the step (4) on the surface of a flat plate, and then heating at the temperature of about 90 ℃ to evaporate the water on the surface of the capsule shell glue solution to obtain a soft capsule with certain toughness;
s6, pressing soft capsules: putting the soft capsule obtained in the step 5 on an automatic rotary capsule pricking machine, adding the mixed solution obtained in the step 3, and pressing into soft capsules;
s7, packaging and warehousing: and (4) drying the soft capsules obtained in the step (6), inspecting the soft capsules, sterilizing at 55 ℃ after the soft capsules are qualified, then externally packaging the soft capsules, and warehousing and storing the soft capsules.
Embodiment 2, a compound allicin soft capsule, which consists of capsule content and capsule skin, wherein the capsule content comprises the following components in percentage by mass: allicin: 65% and houttuynin: 35 percent, and the capsule skin comprises the following components in percentage by mass: gelatin: 15%, plasticizer: 5% of additive: 5% and water: 75 percent.
Figure RE-GDA0002633843180000051
A preparation and packaging method of a compound allicin soft capsule comprises the following steps:
s1, preparing a solution I: weighing allicin according to the formula proportion, adding into partial water, heating and stirring until the allicin is completely dissolved;
s2, preparing a solution II: weighing houttuynin according to the formula proportion, adding part of water, mixing uniformly, and stirring to dissolve completely;
s3, mixing and stirring: adding a certain amount of the first solution into a certain amount of the second solution according to the formula proportion, and stirring until the first solution is completely dissolved to obtain a mixed solution;
s4, preparing a capsule shell glue solution: weighing gelatin, plasticizer, additive and water according to a formula ratio, firstly putting the gelatin into the water, soaking to swell the gelatin, adding the plasticizer and the additive after the gelatin is dissolved, and then mixing and stirring uniformly to obtain capsule shell glue solution;
s5, preparing a capsule shell: uniformly coating the capsule shell glue solution obtained in the step (4) on the surface of a flat plate, and then heating at the temperature of about 90 ℃ to evaporate the water on the surface of the capsule shell glue solution to obtain a soft capsule with certain toughness;
s6, pressing soft capsules: putting the soft capsule obtained in the step 5 on an automatic rotary capsule pricking machine, adding the mixed solution obtained in the step 3, and pressing into soft capsules;
s7, packaging and warehousing: and (4) drying the soft capsules obtained in the step (6), inspecting the soft capsules, sterilizing at 55 ℃ after the soft capsules are qualified, then externally packaging the soft capsules, and warehousing and storing the soft capsules.
In the present invention, unless otherwise expressly specified or limited, the terms "mounted," "disposed," "connected," "secured," "screwed" and the like are to be construed broadly, e.g., as meaning fixedly connected, detachably connected, or integrally formed; can be mechanically or electrically connected; the terms may be directly connected or indirectly connected through an intermediate, and may be communication between two elements or interaction relationship between two elements, unless otherwise specifically limited, and the specific meaning of the terms in the present invention will be understood by those skilled in the art according to specific situations.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (7)

1. The compound allicin soft capsule is characterized by comprising capsule contents and a capsule skin, wherein the capsule contents comprise the following components in percentage by mass: allicin: 1% -65% and houttuynin: 1% -55%, wherein the capsule shell comprises the following components in percentage by mass: sizing and excipient: 10% -20%, plasticizer: 1-10%, additive: 1-10% and water: 50 to 80 percent.
2. The compound allicin soft capsule of claim 1, which is characterized in that: the chemical formula of the allicin is C6H10S3And the garlicin is obtained by purifying natural plant garlic or artificially synthesizing.
3. The compound Chinese medicinal preparation according to claim 1The allicin soft capsule is characterized in that: the houttuynin has chemical formula of C12H22O2The houttuynin is obtained by purifying or artificially synthesizing natural plant houttuynia cordata.
4. The compound allicin soft capsule of claim 1, which is characterized in that: the sizing excipient is gelatin.
5. The compound allicin soft capsule of claim 1, which is characterized in that: the plasticizer is sorbitol or glycerol.
6. The compound allicin soft capsule of claim 1, which is characterized in that: the additive is perfume, antiseptic or sunscreen agent.
7. A preparation and packaging method of a compound allicin soft capsule is characterized in that: the method comprises the following steps:
s1, preparing a solution I: weighing allicin according to the formula proportion, adding into partial water, heating and stirring until the allicin is completely dissolved;
s2, preparing a solution II: weighing houttuynin according to the formula proportion, adding part of water, mixing uniformly, and stirring to dissolve completely;
s3, mixing and stirring: adding a certain amount of the first solution into a certain amount of the second solution according to the formula proportion, and stirring until the first solution is completely dissolved to obtain a mixed solution;
s4, preparing a capsule shell glue solution: weighing gelatin, plasticizer, additive and water according to a formula ratio, firstly putting the gelatin into the water, soaking to swell the gelatin, adding the plasticizer and the additive after the gelatin is dissolved, and then mixing and stirring uniformly to obtain capsule shell glue solution;
s5, preparing a capsule shell: uniformly coating the capsule shell glue solution obtained in the step (4) on the surface of a flat plate, and then heating at the temperature of about 90 ℃ to evaporate the water on the surface of the capsule shell glue solution to obtain a soft capsule with certain toughness;
s6, pressing soft capsules: putting the soft capsule obtained in the step 5 on an automatic rotary capsule pricking machine, adding the mixed solution obtained in the step 3, and pressing into soft capsules;
s7, packaging and warehousing: and (4) drying the soft capsules obtained in the step (6), inspecting the soft capsules, sterilizing at 55 ℃ after the soft capsules are qualified, then externally packaging the soft capsules, and warehousing and storing the soft capsules.
CN202010328287.6A 2020-04-23 2020-04-23 Compound allicin soft capsule and preparation and packaging method thereof Pending CN111700886A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010328287.6A CN111700886A (en) 2020-04-23 2020-04-23 Compound allicin soft capsule and preparation and packaging method thereof
PCT/CN2020/135064 WO2021212865A1 (en) 2020-04-23 2020-12-10 Compound allicin soft capsule and method for preparing and packaging same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010328287.6A CN111700886A (en) 2020-04-23 2020-04-23 Compound allicin soft capsule and preparation and packaging method thereof

Publications (1)

Publication Number Publication Date
CN111700886A true CN111700886A (en) 2020-09-25

Family

ID=72537063

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010328287.6A Pending CN111700886A (en) 2020-04-23 2020-04-23 Compound allicin soft capsule and preparation and packaging method thereof

Country Status (2)

Country Link
CN (1) CN111700886A (en)
WO (1) WO2021212865A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021212865A1 (en) * 2020-04-23 2021-10-28 广州宏康医药科技有限公司 Compound allicin soft capsule and method for preparing and packaging same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1189365A (en) * 1997-01-31 1998-08-05 雷学军 Medicine for preventing Aids virus, treponema pallidum, neisseria gonorrhoeae and trichomonad
US20060257436A1 (en) * 2003-04-04 2006-11-16 Shiseido Company, Ltd. Skin preparation composition for external use
CN101313983A (en) * 2008-07-02 2008-12-03 王跃进 Compound garlic soft capsule
CN110158343A (en) * 2019-05-30 2019-08-23 陈兴龙 A kind of preparation method of antibacterial vapor-permeable type fruit inspecting
CN110898027A (en) * 2019-12-12 2020-03-24 陕西鹤鸣健康科技有限公司 Vitamin K2 (MK-7) soft capsule for promoting calcium in blood to enter bone and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100389676C (en) * 2004-09-24 2008-05-28 江西本草天工科技有限责任公司 Health-care food and its soft capsule for improving immunity of anti alimentary canal infection, and its prepn. method
CN100551434C (en) * 2004-11-08 2009-10-21 钟虹光 A kind of food antibiotic and preparation method thereof
CN1879788A (en) * 2006-05-03 2006-12-20 苟春虎 Virus-clearing capsule
CN111700886A (en) * 2020-04-23 2020-09-25 广州宏康医药科技有限公司 Compound allicin soft capsule and preparation and packaging method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1189365A (en) * 1997-01-31 1998-08-05 雷学军 Medicine for preventing Aids virus, treponema pallidum, neisseria gonorrhoeae and trichomonad
US20060257436A1 (en) * 2003-04-04 2006-11-16 Shiseido Company, Ltd. Skin preparation composition for external use
CN101313983A (en) * 2008-07-02 2008-12-03 王跃进 Compound garlic soft capsule
CN110158343A (en) * 2019-05-30 2019-08-23 陈兴龙 A kind of preparation method of antibacterial vapor-permeable type fruit inspecting
CN110898027A (en) * 2019-12-12 2020-03-24 陕西鹤鸣健康科技有限公司 Vitamin K2 (MK-7) soft capsule for promoting calcium in blood to enter bone and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
REGISTRY: "2050-87-5", 《STN》 *
REGISTRY: "56505-80-7", 《STN》 *
汤光等: "《临床合理用药手册》", 31 January 1995, 浙江科学技术出版社 *
茹仁萍等主编: "《抗感染药物临床合理应用手册》", 30 November 2016, 中国医药科技出版社 *
赵志刚等: "盐酸小檗碱、鱼腥草素钠和大蒜素的体外抗菌活性", 《中国临床药理学杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021212865A1 (en) * 2020-04-23 2021-10-28 广州宏康医药科技有限公司 Compound allicin soft capsule and method for preparing and packaging same

Also Published As

Publication number Publication date
WO2021212865A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
PT71727A (en) Process for preparing a pharmaceutical composition particularly suitable for cancer treatment
EP2030612B1 (en) Pharmaceutical composition for treating burns and a method for the production thereof
CN104257639A (en) Film coating agent for wound surface treatment and preparation method of film coating agent
CN103127025B (en) The preparation method of racemization 2-(Alpha-hydroxy amyl group) benzoate sheet
CN111700886A (en) Compound allicin soft capsule and preparation and packaging method thereof
CN103655469A (en) Prescription and preparation technology of lipoic acid injection combination
JP2019516706A (en) Novel crystalline form of dapagliflozin and method for producing and use thereof
CN106727578A (en) Compound Sulfachorpyrdazine Sodium Powder and preparation method thereof
CN102440979A (en) Cellulose derivative composite film and preparation method thereof
AU2020327255A1 (en) Pharmaceutical composition containing nitroxoline, nitroxoline oral solid tablet, preparation method therefor and use thereof
CN103301468B (en) The luteolin composition of high-load
CN101199514B (en) Ketoralac ammonia butanetriol injection and preparing method thereof
CN110559270B (en) Sitagliptin phosphate pharmaceutical composition and preparation method thereof
CN111892634B (en) Glucoside compound from raw materials, extraction method and application thereof
CN110016022B (en) Palmatine hydrochloride-naringenin pharmaceutical co-crystal with slow release effect
CN106075456A (en) A kind of pleasure that contains cuts down the pharmaceutical composition for Buddhist nun and application thereof
CN105982878A (en) Norfloxacin capsules and preparation method thereof
CN102284062B (en) Capsule shell composition for soft capsule containing ciclosporin, preparation method thereof and soft capsule containing ciclosporin prepared thereby
CN114224860B (en) Glucosamine calcium tablet preparation and preparation method and application thereof
CN201299812Y (en) Tablet capsule used for treating helicobacter pylori (HP) infection
CN1190196C (en) Anti-inflammation antibiotic external used synthesized medicine, soluble hemostatic gauze and method for making the same
CN103330711B (en) Flucloxacillin sodium and amoxicillin sodium for injection
CN113521067B (en) Famotidine zinc gluconate preparation composition and preparation method thereof
CN114652676A (en) Novel phloroglucinol and trimethyl phloroglucinol injection preparation method
CN1651021A (en) Ginseng royal jelly soft capsule and its preparation process

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200925

RJ01 Rejection of invention patent application after publication